| abstract |
Embodiments of the present disclosure provide a peptoid, which is a compound of formula I or a pharmaceutically acceptable salt thereof, wherein N-R 4 , N-R 3 , N-R 2 , and N-R 1 in formula I are respectively The peptide has strong binding ability to EpCAM protein, and can be used as a molecular probe for EpCAM protein-related diseases, and can achieve targeted therapy, in vivo imaging diagnosis and prognosis of EpCAM protein-related diseases with low cost, precision and efficiency monitor. |